Pituitary-adrenocortical hyperfunction and intolerance to fluvoxamine, a selective serotonin uptake inhibitor.
作者信息
Brown W A, Arato M, Shrivastava R
出版信息
Am J Psychiatry. 1986 Jan;143(1):88-90. doi: 10.1176/ajp.143.1.88.
PMID:3079969
Abstract
Of nine nonsuppressors on the dexamethasone suppression test (DST), five (56%) developed intolerable side effects during treatment with fluvoxamine, a new serotonin uptake inhibiting antidepressant, compared with three of 24 suppressors (13%).
摘要
Zotero 插件